Total Funding
45
50
Total FundingSeries B raised
Growth Score
0 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
19263
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.
- Jeff Aronin: Chairman and Co-founderPast Role: Lundbeck, President and CEO
- Rama Ranganathan: Co-Founder, Chief Scientist
About the Company
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development. It is a biotechnology company that specializes in protein design and molecular scale. Its mission is to unlock the potential of novel proteins to solve complex human and societal challenges by revolutionizing protein design.
It was founded in 2020 and
is headquartered in Chicago, Illinois.
